Clinical Trial Update: Prophylactic Amnioinfusion for Prevention of Postpartum Hemorrhage [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating prophylactic amnioinfusion to prevent postpartum hemorrhage is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Amnioinfusion (amnioinfusion)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Postpartum Hemorrhage | Phase 3 | Status: NOT_YET_RECRUITING